2019 as well as having the enhancing cost control measures. The details of the Company's performance were as follows: 2018 2019 YoY Mio. % Mio. % Mio. % Rental and Service Income 534.1 58.3% 465.9 50.2
, with 0.18 million baht decrease with no significantly transaction changes. 2. Cost of sale , Profit margin For Quarter 1 of the year 2020, the company had cost of sale of 98.36 million bath compare to
million or 7%, mainly due to an increase in cost of real estate sold which varied with an increase in revenue from sales of real estate. Page 3 of 4 IV Expense (Unit: Million Baht) Second quarter 6-month
) Expense Quarter 2/2020 company and its subsidiaries has total expenses of 607.05 Million Baht as 227.63 Million Baht decreased from same period of year 2019 which has total expenses of 834.68 Million Baht
Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th 3-Month Period Ending March 31st 2020 2019 Change MB % MB % MB % Cost of Sales 35.76
in loans 154 569 (415) (73.0) Others 1 0 1 n.a. Interest expenses totaled Baht 1,043 million, a decline of 3.6% yoy. Interest expense on debt issued and borrowings reduced by 34.8% from the decline in
lower electricity cost. The average selling price in this quarter was at THB 18,133 per ton, increased 6.5% from the previous quarter, partly due to the increase in market price worldwide, especially in
for the openness of the free trade policy Economic expansion in the developing countries and the continued growth of low-cost airlines, especially in Asia. For the total multi-products fuel